This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Georgia Tech Research Corporation. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Raquel L Lieberman: Innovator in Myocilin-Binding Agents
Introduction
Raquel L Lieberman is a prominent inventor based in Atlanta, GA. She has made significant contributions to the field of biochemistry, particularly in the development of antibodies that target natively folded myocilin. Her innovative work has the potential to impact various medical applications.
Latest Patents
Raquel L Lieberman holds a patent for "Antibodies that bind to natively folded myocilin." This patent includes myocilin-binding agents, such as antibodies and antigen-binding fragments, as well as fusion proteins that specifically bind to the coiled-coil domain of myocilin. Importantly, these agents do not bind to misfolded myocilin, making them useful for the detection and extraction of natively folded myocilin from samples. She has 1 patent to her name.
Career Highlights
Raquel is affiliated with the Georgia Tech Research Corporation, where she continues to advance her research and innovations. Her work is characterized by a commitment to scientific excellence and a focus on practical applications of her discoveries.
Collaborations
Some of her notable coworkers include Shannon E Hill and Athena Patterson-Orazem. Their collaborative efforts contribute to the ongoing research and development in the field of myocilin-binding agents.
Conclusion
Raquel L Lieberman is a trailblazer in the field of biochemistry, with her innovative patents paving the way for advancements in medical diagnostics and treatment. Her contributions are invaluable to the scientific community and hold promise for future breakthroughs.